Mar 16,2022 | Biotechnology
Synthetic biology is defined as a field of science that involves reforming natural organisms with desirable traits for useful purposes. Just like any other organism, plants and animals also use their genes to pass on their qualities. Researchers and companies in the field of Synthetic Biology are joining the power of nature to help with a better harvest, eradicate pests and diseases, as well as improve the efficiency and nutritional value in crop and livestock productivity.
The study scope includes core synthetic biology products (e.g., oligonucleotides, synthetic genes, BioBrick parts, delivery plasmids, chassis organisms, synthetic cells, cell-based and cell-free production systems), enabling technologies (e.g., DNA sequencing, DNA synthesis, gene editing, bioinformatics, specialty media) and enabled technologies (e.g., healthcare, industrial chemicals, consumer products, food and beverage, agriculture) that are already commercialized or are forecast to be commercialized through 2026.
Key synthetic biology technologies and products are analysed to determine present and future market status, as well as forecasted growth from 2021 to 2026. An in-depth discussion of strategic alliances, industry structures, competitive dynamics, patents and market-driving forces is also provided. The latest report offered by Bharatbook under the Life Sciences market reports, examines the Synthetic Biology Industry by market segment, including DNA sequencing, DNA synthesis, gene editing, synthetic biology foundries and software; as well as the agriculture; consumer products, cosmetics and skin care, food and beverage, healthcare and industrial chemicals enable product sectors.
The role of key strategic alliances and acquisitions from 2018 to 2020 is discussed. Emerging markets, including synthetic genes, synthetic-biology-enabled drugs and vaccines, genome-edited crops and chassis organisms; as well as metabolically engineered factories for producing synthetic fuels and specialty chemicals, are analysed and more than 215 companies in these fields are highlighted.
Furthermore the report includes an up-to-date review and analysis of the global market for synthetic biology within the life science industry, evaluation and forecast the global synthetic biology market size, forecasted growth trends, and corresponding market share analysis by product type, end-user industry and region, intellectual property landscape and information on synthetic biology industry M&A deals, development of commercially viable products and technologies, and other strategic alliances within the industry. Major players include Agilent Technologies Inc., Eurofins Scientific, GenScript, Merck KGaA, Novozymes A/S, Thermo Fisher Scientific Inc. and Twist Bioscience.
For more details, we suggest to visit Synthetic Biology: Global Markets.